UniProt ID | SMCE1_HUMAN | |
---|---|---|
UniProt AC | Q969G3 | |
Protein Name | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 | |
Gene Name | SMARCE1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 411 | |
Subcellular Localization | Nucleus . | |
Protein Description | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Required for the coactivation of estrogen responsive promoters by SWI/SNF complexes and the SRC/p160 family of histone acetyltransferases (HATs). Also specifically interacts with the CoREST corepressor resulting in repression of neuronal specific gene promoters in non-neuronal cells.. | |
Protein Sequence | MSKRPSYAPPPTPAPATQMPSTPGFVGYNPYSHLAYNNYRLGGNPGTNSRVTASSGITIPKPPKPPDKPLMPYMRYSRKVWDQVKASNPDLKLWEIGKIIGGMWRDLTDEEKQEYLNEYEAEKIEYNESMKAYHNSPAYLAYINAKSRAEAALEEESRQRQSRMEKGEPYMSIQPAEDPDDYDDGFSMKHTATARFQRNHRLISEILSESVVPDVRSVVTTARMQVLKRQVQSLMVHQRKLEAELLQIEERHQEKKRKFLESTDSFNNELKRLCGLKVEVDMEKIAAEIAQAEEQARKRQEEREKEAAEQAERSQSSIVPEEEQAANKGEEKKDDENIPMETEETHLEETTESQQNGEEGTSTPEDKESGQEGVDSMAEEGTSDSNTGSESNSATVEEPPTDPIPEDEKKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSKRPSYAP ------CCCCCCCCC | 37.05 | 21406692 | |
3 | Trimethylation | -----MSKRPSYAPP -----CCCCCCCCCC | 68.01 | - | |
3 | Acetylation | -----MSKRPSYAPP -----CCCCCCCCCC | 68.01 | 23749302 | |
3 | Methylation | -----MSKRPSYAPP -----CCCCCCCCCC | 68.01 | 23644510 | |
3 | Sumoylation | -----MSKRPSYAPP -----CCCCCCCCCC | 68.01 | 28112733 | |
4 | Methylation | ----MSKRPSYAPPP ----CCCCCCCCCCC | 20.35 | 24129315 | |
6 | Phosphorylation | --MSKRPSYAPPPTP --CCCCCCCCCCCCC | 37.65 | 21406692 | |
7 | Phosphorylation | -MSKRPSYAPPPTPA -CCCCCCCCCCCCCC | 26.30 | 21406692 | |
12 | Phosphorylation | PSYAPPPTPAPATQM CCCCCCCCCCCCCCC | 37.54 | 21406692 | |
17 | Phosphorylation | PPTPAPATQMPSTPG CCCCCCCCCCCCCCC | 25.09 | 21406692 | |
21 | Phosphorylation | APATQMPSTPGFVGY CCCCCCCCCCCCCCC | 41.72 | 21406692 | |
22 | Phosphorylation | PATQMPSTPGFVGYN CCCCCCCCCCCCCCC | 22.89 | 28655764 | |
28 | Phosphorylation | STPGFVGYNPYSHLA CCCCCCCCCCCCCEE | 13.99 | 21406692 | |
31 | Phosphorylation | GFVGYNPYSHLAYNN CCCCCCCCCCEEECC | 12.70 | 17360941 | |
32 | Phosphorylation | FVGYNPYSHLAYNNY CCCCCCCCCEEECCC | 17.18 | 21406692 | |
36 | Phosphorylation | NPYSHLAYNNYRLGG CCCCCEEECCCCCCC | 15.42 | 21406692 | |
39 | Phosphorylation | SHLAYNNYRLGGNPG CCEEECCCCCCCCCC | 11.99 | 21406692 | |
40 | Methylation | HLAYNNYRLGGNPGT CEEECCCCCCCCCCC | 29.04 | 24129315 | |
47 | Phosphorylation | RLGGNPGTNSRVTAS CCCCCCCCCCCEEEC | 31.14 | 27251275 | |
52 | Phosphorylation | PGTNSRVTASSGITI CCCCCCEEECCCCCC | 21.51 | 20068231 | |
54 | Phosphorylation | TNSRVTASSGITIPK CCCCEEECCCCCCCC | 21.52 | 20068231 | |
55 | Phosphorylation | NSRVTASSGITIPKP CCCEEECCCCCCCCC | 31.58 | 20068231 | |
57 | Ubiquitination | RVTASSGITIPKPPK CEEECCCCCCCCCCC | 3.22 | 21890473 | |
58 | Phosphorylation | VTASSGITIPKPPKP EEECCCCCCCCCCCC | 34.45 | 20068231 | |
73 | Phosphorylation | PDKPLMPYMRYSRKV CCCCCCCCCHHCHHH | 4.73 | - | |
85 | Ubiquitination | RKVWDQVKASNPDLK HHHHHHHHHHCCCCH | 40.23 | - | |
92 | Ubiquitination | KASNPDLKLWEIGKI HHHCCCCHHHHHHHH | 59.96 | 21890473 | |
92 | Ubiquitination | KASNPDLKLWEIGKI HHHCCCCHHHHHHHH | 59.96 | 21890473 | |
92 | Sumoylation | KASNPDLKLWEIGKI HHHCCCCHHHHHHHH | 59.96 | - | |
92 | Acetylation | KASNPDLKLWEIGKI HHHCCCCHHHHHHHH | 59.96 | 25953088 | |
92 | Sumoylation | KASNPDLKLWEIGKI HHHCCCCHHHHHHHH | 59.96 | 25114211 | |
92 | Ubiquitination | KASNPDLKLWEIGKI HHHCCCCHHHHHHHH | 59.96 | 21890473 | |
92 (in isoform 1) | Ubiquitination | - | 59.96 | 21890473 | |
92 (in isoform 2) | Ubiquitination | - | 59.96 | 21890473 | |
98 | Ubiquitination | LKLWEIGKIIGGMWR CHHHHHHHHHHHHHH | 36.49 | - | |
112 | Acetylation | RDLTDEEKQEYLNEY HCCCHHHHHHHHHHH | 46.51 | 26051181 | |
112 | Ubiquitination | RDLTDEEKQEYLNEY HCCCHHHHHHHHHHH | 46.51 | - | |
115 | Phosphorylation | TDEEKQEYLNEYEAE CHHHHHHHHHHHHHH | 16.60 | - | |
123 | Acetylation | LNEYEAEKIEYNESM HHHHHHHHCCCCHHH | 48.13 | 26051181 | |
129 | Phosphorylation | EKIEYNESMKAYHNS HHCCCCHHHHHHCCC | 23.19 | 22817901 | |
131 | Ubiquitination | IEYNESMKAYHNSPA CCCCHHHHHHCCCHH | 55.88 | 21890473 | |
131 | Ubiquitination | IEYNESMKAYHNSPA CCCCHHHHHHCCCHH | 55.88 | 21890473 | |
131 | Ubiquitination | IEYNESMKAYHNSPA CCCCHHHHHHCCCHH | 55.88 | 21890473 | |
131 | Sumoylation | IEYNESMKAYHNSPA CCCCHHHHHHCCCHH | 55.88 | 28112733 | |
131 | Ubiquitination | IEYNESMKAYHNSPA CCCCHHHHHHCCCHH | 55.88 | 21890473 | |
131 (in isoform 1) | Ubiquitination | - | 55.88 | 21890473 | |
131 (in isoform 2) | Ubiquitination | - | 55.88 | 21890473 | |
133 | Phosphorylation | YNESMKAYHNSPAYL CCHHHHHHCCCHHHH | 8.94 | 29759185 | |
136 | Phosphorylation | SMKAYHNSPAYLAYI HHHHHCCCHHHHHHH | 9.52 | 25159151 | |
139 | Phosphorylation | AYHNSPAYLAYINAK HHCCCHHHHHHHCHH | 8.68 | 28152594 | |
142 | Phosphorylation | NSPAYLAYINAKSRA CCHHHHHHHCHHHHH | 7.66 | 28152594 | |
146 | Ubiquitination | YLAYINAKSRAEAAL HHHHHCHHHHHHHHH | 35.67 | 21890473 | |
146 | Ubiquitination | YLAYINAKSRAEAAL HHHHHCHHHHHHHHH | 35.67 | 21890473 | |
146 | Acetylation | YLAYINAKSRAEAAL HHHHHCHHHHHHHHH | 35.67 | 25953088 | |
146 | Malonylation | YLAYINAKSRAEAAL HHHHHCHHHHHHHHH | 35.67 | 26320211 | |
146 | Sumoylation | YLAYINAKSRAEAAL HHHHHCHHHHHHHHH | 35.67 | 28112733 | |
146 | Ubiquitination | YLAYINAKSRAEAAL HHHHHCHHHHHHHHH | 35.67 | 21890473 | |
146 (in isoform 1) | Ubiquitination | - | 35.67 | 21890473 | |
146 (in isoform 2) | Ubiquitination | - | 35.67 | 21890473 | |
157 | Phosphorylation | EAALEEESRQRQSRM HHHHHHHHHHHHHHH | 36.67 | 20068231 | |
162 | Phosphorylation | EESRQRQSRMEKGEP HHHHHHHHHHHCCCC | 35.47 | 26657352 | |
166 | Sumoylation | QRQSRMEKGEPYMSI HHHHHHHCCCCCCCC | 60.27 | 28112733 | |
166 | Ubiquitination | QRQSRMEKGEPYMSI HHHHHHHCCCCCCCC | 60.27 | - | |
166 (in isoform 2) | Ubiquitination | - | 60.27 | - | |
170 | Ubiquitination | RMEKGEPYMSIQPAE HHHCCCCCCCCCCCC | 10.13 | 21890473 | |
170 | Phosphorylation | RMEKGEPYMSIQPAE HHHCCCCCCCCCCCC | 10.13 | 17360941 | |
172 | Phosphorylation | EKGEPYMSIQPAEDP HCCCCCCCCCCCCCC | 16.54 | 28555341 | |
182 | Phosphorylation | PAEDPDDYDDGFSMK CCCCCCCCCCCCCCC | 24.26 | 18767875 | |
187 | Phosphorylation | DDYDDGFSMKHTATA CCCCCCCCCCHHHHH | 32.24 | 24719451 | |
189 | Ubiquitination | YDDGFSMKHTATARF CCCCCCCCHHHHHHH | 36.28 | - | |
189 (in isoform 2) | Ubiquitination | - | 36.28 | - | |
191 | Phosphorylation | DGFSMKHTATARFQR CCCCCCHHHHHHHHH | 21.86 | - | |
193 | Phosphorylation | FSMKHTATARFQRNH CCCCHHHHHHHHHHH | 21.37 | - | |
201 | Ubiquitination | ARFQRNHRLISEILS HHHHHHHHHHHHHHC | 36.95 | 21890473 | |
204 | Phosphorylation | QRNHRLISEILSESV HHHHHHHHHHHCCCC | 24.15 | 28857561 | |
208 | Phosphorylation | RLISEILSESVVPDV HHHHHHHCCCCCCCH | 33.22 | 28270605 | |
210 | Phosphorylation | ISEILSESVVPDVRS HHHHHCCCCCCCHHH | 25.66 | 28270605 | |
214 | Ubiquitination | LSESVVPDVRSVVTT HCCCCCCCHHHHHHH | 36.53 | 21890473 | |
228 | Methylation | TARMQVLKRQVQSLM HHHHHHHHHHHHHHH | 41.76 | 115980931 | |
240 | Acetylation | SLMVHQRKLEAELLQ HHHHHHHHHHHHHHH | 44.07 | 26051181 | |
240 | Ubiquitination | SLMVHQRKLEAELLQ HHHHHHHHHHHHHHH | 44.07 | 21906983 | |
240 (in isoform 1) | Ubiquitination | - | 44.07 | 21890473 | |
240 (in isoform 2) | Ubiquitination | - | 44.07 | 21890473 | |
258 | Ubiquitination | RHQEKKRKFLESTDS HHHHHHHHHHHCCHH | 64.28 | 21890473 | |
258 | Ubiquitination | RHQEKKRKFLESTDS HHHHHHHHHHHCCHH | 64.28 | 21890473 | |
258 | Ubiquitination | RHQEKKRKFLESTDS HHHHHHHHHHHCCHH | 64.28 | 21890473 | |
258 | Acetylation | RHQEKKRKFLESTDS HHHHHHHHHHHCCHH | 64.28 | 25953088 | |
258 | Ubiquitination | RHQEKKRKFLESTDS HHHHHHHHHHHCCHH | 64.28 | 21890473 | |
258 (in isoform 1) | Ubiquitination | - | 64.28 | 21890473 | |
258 (in isoform 2) | Ubiquitination | - | 64.28 | 21890473 | |
262 | Phosphorylation | KKRKFLESTDSFNNE HHHHHHHCCHHHHHH | 39.39 | 30108239 | |
263 | Phosphorylation | KRKFLESTDSFNNEL HHHHHHCCHHHHHHH | 26.70 | 19690332 | |
265 | Phosphorylation | KFLESTDSFNNELKR HHHHCCHHHHHHHHH | 29.93 | 25159151 | |
271 | Ubiquitination | DSFNNELKRLCGLKV HHHHHHHHHHHCCCE | 36.83 | 21890473 | |
271 | Ubiquitination | DSFNNELKRLCGLKV HHHHHHHHHHHCCCE | 36.83 | 21890473 | |
271 | 2-Hydroxyisobutyrylation | DSFNNELKRLCGLKV HHHHHHHHHHHCCCE | 36.83 | - | |
271 | Acetylation | DSFNNELKRLCGLKV HHHHHHHHHHHCCCE | 36.83 | 25953088 | |
271 | Ubiquitination | DSFNNELKRLCGLKV HHHHHHHHHHHCCCE | 36.83 | 21890473 | |
271 (in isoform 1) | Ubiquitination | - | 36.83 | 21890473 | |
271 (in isoform 2) | Ubiquitination | - | 36.83 | 21890473 | |
277 | Sumoylation | LKRLCGLKVEVDMEK HHHHHCCCEEECHHH | 22.95 | - | |
277 | Acetylation | LKRLCGLKVEVDMEK HHHHHCCCEEECHHH | 22.95 | 26051181 | |
277 | Sumoylation | LKRLCGLKVEVDMEK HHHHHCCCEEECHHH | 22.95 | 28112733 | |
277 | Ubiquitination | LKRLCGLKVEVDMEK HHHHHCCCEEECHHH | 22.95 | - | |
284 | Ubiquitination | KVEVDMEKIAAEIAQ CEEECHHHHHHHHHH | 30.89 | 2190698 | |
284 (in isoform 1) | Ubiquitination | - | 30.89 | 21890473 | |
284 (in isoform 2) | Ubiquitination | - | 30.89 | 21890473 | |
314 | Phosphorylation | AAEQAERSQSSIVPE HHHHHHHHHHCCCCH | 26.39 | 29255136 | |
316 | Phosphorylation | EQAERSQSSIVPEEE HHHHHHHHCCCCHHH | 24.23 | 29255136 | |
317 | Phosphorylation | QAERSQSSIVPEEEQ HHHHHHHCCCCHHHH | 21.70 | 25159151 | |
328 | Acetylation | EEEQAANKGEEKKDD HHHHHHHCCCCCCCC | 64.07 | 23236377 | |
328 | Ubiquitination | EEEQAANKGEEKKDD HHHHHHHCCCCCCCC | 64.07 | - | |
342 | Phosphorylation | DENIPMETEETHLEE CCCCCCCCCCHHHHH | 32.63 | 20873877 | |
345 | Phosphorylation | IPMETEETHLEETTE CCCCCCCHHHHHHCH | 26.06 | 23663014 | |
350 | Phosphorylation | EETHLEETTESQQNG CCHHHHHHCHHHHCC | 26.87 | 23663014 | |
351 | Phosphorylation | ETHLEETTESQQNGE CHHHHHHCHHHHCCC | 36.60 | 23663014 | |
353 | Phosphorylation | HLEETTESQQNGEEG HHHHHCHHHHCCCCC | 34.67 | 28348404 | |
361 | Phosphorylation | QQNGEEGTSTPEDKE HHCCCCCCCCHHHHH | 32.48 | 23663014 | |
362 | Phosphorylation | QNGEEGTSTPEDKES HCCCCCCCCHHHHHC | 53.47 | 23663014 | |
363 | Phosphorylation | NGEEGTSTPEDKESG CCCCCCCCHHHHHCC | 30.45 | 28348404 | |
376 | Phosphorylation | SGQEGVDSMAEEGTS CCCCCHHHHHHCCCC | 19.93 | 30576142 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SMCE1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMCE1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
607174 | Meningioma (MNGMA) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265, AND MASSSPECTROMETRY. |